3 New Strong Buy Ratings from Top-Rated Analysts: 12/19/2025

By Jessie Moore, Stock Researcher and Writer
December 18, 2025 5:14 PM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 12/19/2025

Both analysts and our Zen Ratings agree: These stocks are worth watching.

  • Jazz Pharmaceuticals (JAZZ) gains momentum amid pipeline advances 
  • Flowserve (FLS) sets the stage for clean growth ahead 
  • Micron Technology (MU): Better than NVDA? 

P.S. Get more alerts like this daily … Try WallStreetZen Premium.


A note from our sponsors...

What's Nvidia's Dirty Secret? Nvidia's charging into two seismic tech frontiers projected to be worth over $24 TRILLION! And they're in a race to dominate first. But here's the dirty secret Nvidia won't admit... They can't do it alone. Nvidia needs 3 Silent Partners... This $24 trillion pivot hinges on them. Click here now and find out about 3 companies critical to Nvidia's success in 2026.

1. Jazz Pharmaceuticals (NASDAQ: JAZZ)

Jazz Pharmaceuticals is gaining momentum as key pipeline advances and upcoming pivotal data for its cancer therapy Ziihera put the company on the cusp of a major oncology growth phase.

Zen Rating: A (Strong Buy) see full analysis

Recent Price: $168.94 — get current quote

Max 1-year forecast: $247.00

Why we're watching:

  • Analysts love it: Right now, JAZZ enjoys 7 Strong Buy, 3 Buy, and just 1 Hold among the 11 analysts we follow covering the stock. See the ratings
  • For example, JP Morgan's Jessica Fye (a top 4% rated analyst) recently maintained her Strong Buy rating with a $199 price target, noting that Jazz's strong fundamentals remain a compelling reason to invest with a focus on delivering shareholder value.
  • Piper Sandler's David Amsellem (top 5%) recently reiterated his Strong Buy rating with a $219 price target, continuing to remain bullish on Jazz's growth potential due to its solid pipeline and strategic acquisitions.
  • Zen Rating highlights: Despite being in an iffy industry (Biotechs are volatile, y’all), JAZZ earns the highest Zen Rating possible — A (Strong Buy). Stocks in this tier have historically delivered 32.52% annual returns. 
  • Component Grades: Jazz earns high marks with an A in Value, B in Growth, B in Momentum, B in Safety, B in Financials, and B in AI components, demonstrating balanced strength across multiple dimensions. See all 7 Zen Component Grades here

2. Flowserve Corp (NYSE: FLS)

Flowserve just cleared two major overhangs—acquiring Greenray Turbine Solutions and exiting legacy asbestos liabilities—setting the stage for faster, cleaner growth ahead.

Zen Rating: A (Strong Buy) see full analysis

Recent Price: $69.20 — get current quote

Max 1-year forecast: $85.00

Why we're watching:

  • Analyst support: Flowserve enjoys robust analyst backing with 5 Strong Buy, 1 Buy, and 2 Hold ratings among 8 analysts we track providing coverage. See the ratings
  • For example, Citigroup's Andy Kaplowitz (a top 1% rated analyst) recently maintained a Strong Buy rating with an $82 price target, citing a bullish long-term view supported by strong fundamentals and strategic initiatives with market adaptability.
  • Stifel Nicolaus analyst Nathan Jones (top 2%) maintained a Strong Buy rating with a $66 price target, though cautious about uncertain market conditions while monitoring volatile factors that could impact forecasts. 
  • Industry ranking context: Flowserve is currently the 2nd highest-rated stock of 70 companies in the Specialty Industrial Machinery industry, which has an Industry Rating of A.
  • Zen Rating highlights: FLS is an A-rated (Strong Buy) stock, meaning it’s in the top 5% of the 4600+ tickers we track based on a rigorous review of 115 factors proven to drive stock growth.  
  • Component Grades: Flowserve demonstrates solid fundamentals with a B in Value, B in Sentiment, B in Safety, B in Financials, balanced by a C in Growth and C in Momentum. See all 7 Zen Component Grades here

 

3. Micron Technology Inc (NASDAQ: MU)

Our latest Stock of the Week is heading into Q1 earnings with powerful momentum, as surging AI-driven demand for high-bandwidth memory signals a fresh upcycle in the chip industry.

Zen Rating: Strong Buy (A)see full analysis

Recent Price: $245.75 — get current quote

Max 1-year forecast: $338.00

Why we're watching:

  • Analyst support: The memory leader commands exceptional Wall Street conviction among the analysts we track. It has 16 Strong Buy, 8 Buy, and only 2 Hold ratings among 26 analysts covering the stock. See the ratings
  • For example, Stifel Nicolaus analyst Brian Chin (top 5%) recently maintained a Strong Buy rating with a $300 price target, representing 24% upside potential from current levels. 
  • According to Zen Investor Editor in Chief Steve Reitmeister, who recently spotlighted MU as his Stock of the Week, Micron (MU) offers leveraged exposure to the AI boom at a far cheaper valuation than Nvidia, with explosive earnings growth expected and a fraction of NVDA’s multiple. 
  • Industry ranking context: MU ranks #1 in the Semiconductor industry, which has an Industry Rating of C. 
  • Zen Rating highlights: MU earns the highest Zen Rating possible — A (Strong Buy). Stocks in this tier have historically delivered 32.52% annual returns. 
  • Component Grades: The stock earns strong marks across key factors including an A grade in Momentum, B grades in Value, Growth, and Safety, positioning it as a balanced high-quality semiconductor play. See all 7 Zen Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.